MedPath
HSA Product

TELFAST TABLET 120 mg

Product approved by Health Sciences Authority (SG)

Basic Information

TELFAST TABLET 120 mg

TABLET, FILM COATED

Regulatory Information

SIN11704P

November 1, 2001

General Sale List

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XR06AX26

Company Information

PT Aventis Pharma

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

Active Ingredients

FEXOFENADINE HCl

Strength: 120 mg

Detailed Information

Contraindications

**IS TELFAST SUITABLE FOR ME?** Do not take Telfast, and tell your doctor or pharmacist if: - you have had an allergic reaction to fexofenadine or any of the other ingredients in Telfast. These are listed at the end of this leaflet – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - the expiry date on the pack has passed. It may have no effect or an unexpected effect if it is taken after this date - the packaging is torn or shows signs of tampering

Indication Information

**WHAT IS TELFAST AND WHAT IS IT USED FOR?** Telfast tablets contain an active ingredient called “fexofenadine”. It is one of a group of medicines called antihistamines. Telfast 120mg is used to relieve the symptoms of allergic rhinitis such as sneezing, itchy, red eyes, and runny nose for adults and children aged 12 years and above. Telfast works by blocking the action of histamine which causes these unwanted effects. Telfast is a non-drowsy antihistamine which means it has been shown not to make you drowsy or slow down your reactions.

© Copyright 2025. All Rights Reserved by MedPath